Physician profile

Bridget Singh

Dentist · Seattle, WA

NPI 1578795704

$792.39

in general payments reported to CMS, 2019-2025

7 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$182.86

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
A-Dec, INC. $355.00 2021
Acteon INC $234.00 2021
Align Technology, INC. $119.57 2021-2024 Invisalign, Itero Element 5d Plus
3m Company $34.10 2023 3m Espe Filtek Supreme Ultra Universal Restorative, Filtek, 3m Filtek
Solventum Corporation $22.40 2024 Elipar Deepcure-S, Filtek, 3m Espe Filtek Supreme Ultra Universal Restorative
Dentsply Sirona INC $14.84 2024 Cavitron
Voco America INC. $12.48 2023 Voco Retraction Paste, Futurabond U

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Bridget Singh

$792.39

in general payments reported 2019-2025

Years
2021-2024
Top company
A-Dec, INC.

https://glasscript.com/doctor/493883/bridget-singh

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.